b b b b b b b b
Molecular Diagnostics,
b b b
8th Edition by Nader Rifai, PhD
b b b b b b
Chapters 1 - 49
b b b b
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
b b b b b b b b
b
b b
Table of contents:
b b
I. Principles Of Laboratory Medicine
b b b b
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
b b b b b b b b
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
b b b b b b b b b b b
Chapter 3. Clinical Evaluation of Methods
b b b b b
Chapter 4. Evidence-Based Laboratory Medicine
b b b b
Chapter 5. Establishment and Use of Reference Values
b b b b b b b
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
b b b b b b b b
Chapter 7. Quality Management
b b b
II. Analytical Techniques And Instrumentation
b b b b
Chapter 8. Principles of Basic Techniques and Laboratory Safety
b b b b b b b b
Chapter 9. Optical Techniques
b b b
Chapter 10. Electrochemistry and Chemical Sensors
b b b b b
Chapter 11. Electrophoresis
b b
Chapter 12. Chromatography
b b
Chapter 13. Mass Spectrometry
b b b
Chapter 14. Enzyme and Rate Analyses
b b b b b
Chapter 15. Immunochemical Techniques
b b b
Chapter 16 Automation
b b
Chapter 17. Point-of-Care Instrumentation
b b b
III. Analytes
b
Chapter 18. Amino Acids, Peptides, and Proteins
b b b b b b
Chapter 19. Serum Enzymes
b b b
Chapter 20. Tumor Markers and Cancer Genes
b b b b b b
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
b b b b b b b b b b b
Chapter 22. Carbohydrates
b b
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
b b b b b b b b b
Chapter 24. Electrolytes and Blood Gases
b b b b b
Chapter 25. Hormones
b b
Chapter 26. Catecholamines and Serotonin
b b b b
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
b b b b b b
Chapter 28. Hemoglobin, Iron, and Bilirubin
b b b b b
Chapter 29. Porphyrins and Porphyrias
b b b b
Chapter 30. Therapeutic Drugs and Their Management
b b b b b b
Chapter 31. Clinical Toxicology
b b b
Chapter 32. Toxic Metals
b b b
IV. Pathophysiology
b
Chapter 33. Diabetes
b b
,Chapter 34. Cardiovascular Disease
b b b
Chapter 35. Kidney Disease
b b b
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
b b b b b b b b b b
Chapter 37. Liver Disease
b bb b
Chapter 38. Gastrointestinal and Pancreatic Diseases
b b b b b
Chapter 39. Disorders of Bone and Mineral Metabolism
b bb b b b b b
Chapter 40. Disorders of the Pituitary Gland
b bb b b b b
Chapter 41. Disorders of the Adrenal Cortex
b b b b b b
Chapter 42. Thyroid Disorders
b b b
Chapter 43. Reproduction-Related Disorders
b b b
Chapter 44. Pregnancy and Prenatal Testing
b bb b b b
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
b b b b b b b b
Chapter 46. Pharmacogenetics
b b
V. Molecular Diagnostics
b b
Chapter 47. Principles of Molecular Biology
b b b b b
Chapter 48. Nucleic Acid Techniques and Applications
b b b b b b
Chapter 49. Genomes and Nucleic Acid Alterations
b b b b b b
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
b b b b b b b b
TestBank
b b
MULTIPLE CHOICE b
1. An individual working in a clinical chemistry laboratory is married to a sales representative
b b b b b b b b b b b b b
who works for a company that sells chemistry laboratory supplies. When the laboratory
b b b b b b b b b b b b b
manager requests a list of needed supplies, cost of supplies, and vendors, this individual
b b b b b b b b b b b b b b
onlyrecommends the spouse’s company as the vendor. This is considered to be a(n):
b b b b b b b b b b b b b b
a. accounting issue. b
b. possible conflict of interest. b b b
c. maintenance of confidentiality issue. b b b
d. problem with resource allocation. b b b
ANS: B b
Concern has been raised over the interrelationships between practitioners in the medical
b b b b b b b b b b b
fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
b b b b b b b b b b b b b
Similarly, relationships have been scrutinized between clinical laboratorians and
b b b b b b b b
manufacturers and providers of diagnostic equipment and supplies. These concerns led the
b b b b b b b b b b b b
National Institutes of Health (NIH) in 1995 to require official institutional review of financial
b b b b b b b b b b b b b b
disclosure by researchers and management of situations in which disclosure indicates
b b b b b b b b b b b
potentialconflicts of interest.
b b b b
DIF: 1 REF: Page 4-5 bbb b OBJ: 6 | 7 b b b
2. A patient visits her physician stating that her prescribed painkiller is not working to reduce
b b b b b b b b b b b b b b
the pain following her recent surgery. A friend of the patient claims that the same
b b b b b b b b b b b b b b b
painkiller―worked wonders‖ to reduce her pain after the same surgery. The physician
b b b b b b b b b b b b b
states that the difference in the effect of the drug might be caused by , which is studied
b b b b b b b b b b b b b b b b b
in pharmacogenetics.
b b
a. epidemiology
b. an inherited disease b b
c. a conflict of interest
b b b
d. a genetic variation in drug-metabolizing enzymes
b b b b b
ANS: D b
Pharmacogenetics is the study of the genetic variation of drug metabolism b b b b b b b b b b
betweenindividuals.
b b
DIF: 1 REF: Page 3 bbb b OBJ: 1 b
3. John works in a molecular diagnostics laboratory and receives a blood sample that has the
b b b b b b b b b b b b b b
name of a close friend printed on the bar-coded label. The genetic test that is ordered on
b b b b b b b b b b b b b b b b b
thefriend’s sample would provide diagnostic information about a disorder that has a poor
b b b b b b b b b b b b b b
prognosis, and the test is usually performed by John. He asks a fellow employee to
b b b b b b b b b b b b b b b
analyzethe sample for him and not divulge the results. This ethical issue concerns:
b b b b b b b b b b b b b b
a. confidentiality of patient genetic and medical information. b b b b b b
b. a conflict of interest.
b b b
c. resource allocation. b
d. diagnostic accuracy. b